Table 1

Percentuals of answers to the proposed questions

ANSWERES' PERCENTAGES

PROPOSED QUESTIONS

Yes

No

Others

1. Have you read the Treatment of Type 2 Diabetes algorithm proposed by ADA/EASD?

90

10

-

2. Were you aware that the document expresses the opinion of a few authors and not of the entities involved?

77

23

-

3. Do you intend to adopt the stages and steps suggested by this algorithm in your practice?

51

49

-

4. Do you think that rosiglitazone-associated adverse events have been ratified in the medical literature of excellence?

36

64

-

5. Do you think that the cardiovascular protection assigned topioglitazone in that Position Statement is real?

34

66

-

6. Do you think that glitazone-associated adverse events (bone fracture and cardiovascular events) are effects pertaining to this therapeutical class?

49

21

30

7. Do you think that only GLP-1 analogs should be included in diabetes treatment excluding DPP-4 inhibitors?

13

69

18

8. Do you think that BDS' members have the expertise and the ability of criticism to issue a Position Statement about this Algorithm?

87

4

9

Gomes MB. Enquete sobre Algoritmo ADA/EASD - December 2008 - 217 Sócios da SBD. Available at: http://www.diabetes.org.br/agenda/comunicados/index.php?id=1838 webcite. Accessed on: July 13, 2009.

Lerario et al. Diabetology & Metabolic Syndrome 2010 2:35   doi:10.1186/1758-5996-2-35